IRIS
PETRACCA, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.632
EU - Europa 2.202
NA - Nord America 1.767
SA - Sud America 342
AF - Africa 83
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.033
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.664
SG - Singapore 1.356
RU - Federazione Russa 981
CN - Cina 666
IT - Italia 535
DE - Germania 280
BR - Brasile 276
HK - Hong Kong 241
VN - Vietnam 149
NL - Olanda 76
GB - Regno Unito 73
IN - India 55
FI - Finlandia 54
CA - Canada 53
KR - Corea 43
FR - Francia 42
UA - Ucraina 41
MX - Messico 29
ZA - Sudafrica 27
CI - Costa d'Avorio 26
PL - Polonia 21
AR - Argentina 19
IE - Irlanda 19
BD - Bangladesh 18
SE - Svezia 16
EC - Ecuador 15
ID - Indonesia 15
ES - Italia 14
JP - Giappone 13
LT - Lituania 11
TR - Turchia 10
CO - Colombia 9
SA - Arabia Saudita 9
AT - Austria 8
BE - Belgio 7
IQ - Iraq 7
PE - Perù 6
PK - Pakistan 6
UZ - Uzbekistan 6
MY - Malesia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CH - Svizzera 4
HN - Honduras 4
IL - Israele 4
IR - Iran 4
JO - Giordania 4
MA - Marocco 4
NP - Nepal 4
TN - Tunisia 4
UY - Uruguay 4
AL - Albania 3
BO - Bolivia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
KE - Kenya 3
PY - Paraguay 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
LY - Libia 2
MK - Macedonia 2
NI - Nicaragua 2
RS - Serbia 2
SI - Slovenia 2
TW - Taiwan 2
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
CU - Cuba 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
HT - Haiti 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MN - Mongolia 1
NE - Niger 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PG - Papua Nuova Guinea 1
PH - Filippine 1
PT - Portogallo 1
RE - Reunion 1
RO - Romania 1
Totale 7.027
Salva come PNG Salva come JPEG
Città #
Singapore 695
Ashburn 257
Hefei 250
Hong Kong 237
Moscow 237
Beijing 185
Santa Clara 149
Chandler 117
Naples 110
Los Angeles 89
San Jose 61
Ho Chi Minh City 60
Amsterdam 56
Munich 54
Seoul 43
Dallas 39
Napoli 35
São Paulo 34
Krefeld 33
Millbury 32
Boston 29
New York 29
Buffalo 28
Redondo Beach 26
Lawrence 24
Milan 23
Helsinki 22
Montreal 22
Hanoi 21
Des Moines 20
Frankfurt am Main 20
Falkenstein 19
London 18
Orem 18
Seattle 18
Chicago 16
Mexico City 16
Johannesburg 15
Rottweil 15
Denver 14
Warsaw 14
Chennai 13
Poplar 13
Rome 13
The Dalles 13
Turku 13
Princeton 12
Stockholm 12
Tokyo 12
Toronto 12
Atlanta 11
Nanjing 11
Ottawa 11
Council Bluffs 10
Tianjin 10
Wilmington 10
Boardman 9
Dublin 9
Houston 9
Mumbai 9
Pune 9
Washington 9
Dong Ket 8
Lappeenranta 8
Norwalk 8
Porto Alegre 8
Belo Horizonte 7
Brooklyn 7
Brussels 7
Haiphong 7
Manchester 7
Phoenix 7
Rio de Janeiro 7
Shanghai 7
Ankara 6
Bari 6
Lauterbourg 6
Marano 6
Tashkent 6
Udine 6
Vicenza 6
Arcore 5
Augusta 5
Biên Hòa 5
Brasília 5
Caposele 5
Casoria 5
Charlotte 5
Da Nang 5
Formia 5
Jeddah 5
Querétaro 5
Shenzhen 5
Amman 4
Campinas 4
Caxias do Sul 4
Columbus 4
Curitiba 4
Guangzhou 4
Guayaquil 4
Totale 3.648
Salva come PNG Salva come JPEG
Nome #
Neurologia per le professioni sanitarie 249
AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature 247
MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis 151
GBA-Related Parkinson’s Disease:Dissection of Genotype–Phenotype Correlates in a LargeItalian Cohort 144
2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis 136
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study 133
Quality of Life Changes in Early-Onset Multiple Sclerosis: A 4-Year Follow-Up Study 129
Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis 128
Validation of the Italian version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 128
Peripapillary Vessel Density as Early Biomarker in Multiple Sclerosis 126
Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin 121
The Italian Dystonia Registry: rationale, design and preliminary findings 121
The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease 119
Signs and symptoms of COVID-19 in patients with multiple sclerosis 118
Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis 114
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 112
Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex(®) 112
Cognitive trajectories in multiple sclerosis: a long-term follow-up study 112
Fertility, pregnancy and childbirth in women with multiple sclerosis: a population-based study from 2018 to 2020 110
Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice 110
Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 Outbreak 110
Mental Health in Multiple Sclerosis During the COVID-19 Outbreak: A Delicate Balance between Fear of Contagion and Resilience 107
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study 106
Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions 106
Neurofilament light chain and Alzheimer pathology biomarkers in elderly people with multiple sclerosis 106
ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial 105
COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management 103
Idiopathic late-onset cerebellar ataxia with cerebellar atrophy in a patient diagnosed with Chiari I malformation: a case report. 101
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate. 100
Cerebellum and cognition in progressive MS patients: functional changes beyond atrophy? 100
Cerebellar lobule atrophy and disability in progressive MS 100
Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications 99
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors 99
Multiple sclerosis and systemic sclerosis: efficacy of interferon beta on skin lesions. 99
MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple Sclerosis 98
Assessing brain involvement in Fabry disease with deep learning and the brain‐age paradigm 97
A retrospective exploratory analysis on cardiovascular risk and cognitive dysfunction in multiple sclerosis 97
A Combined Radiomics and Machine Learning Approach to Overcome the Clinicoradiologic Paradox in Multiple Sclerosis 96
Interplay Between Cognitive and Bowel/Bladder Function in Multiple Sclerosis 95
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg 93
Being highly sensitive person negatively impacts on cognitive and psychosocial fatigue in multiple sclerosis patients: A cross-sectional, monocenter study 92
Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study 92
Tolosa-Hunt syndrome in a patient with autoimmune hemolytic anemia. 92
The independent contribution of brain, spinal cord and gadolinium MRI in treatment decision in multiple sclerosis: A population-based retrospective study 92
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region 91
Integration of the expanded disability status scale with ambulation, visual and cognitive tests 89
Sporadic Porphyria Cutanea Tarda in a Patient with Multiple Sclerosis Treated with Interferon Beta 1-a Therapy: A Case Report. 88
Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia 88
Efficacy of levetiracetam in hemifacial spasm: a case report. 87
Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy 85
Clinical application of age-derived cut-offs for plasma neurofilament light chain in multiple sclerosis 85
Adult onset Rasmussen’s Encephalitis: a case report. 85
Quantitative MRI in Multiple Sclerosis: From Theory to Application 83
Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based Study 81
Switching to ozanimod as a strategy to adjust fingolimod-related lymphopenia 80
Glossopharyngeal neuralgia as onset of multiple sclerosis. 78
Walk your talk: Real-world adherence to guidelines on the use of MRI in multiple sclerosis 77
Association between CD20+ T lymphocytes and neuropsychological findings in multiple sclerosis 74
Sexual dysfunction in people with multiple sclerosis: The role of disease severity, illness perception, and depression 70
Google Maps Timeline: An open-access digital tool to monitor walking abilities in people with multiple sclerosis 69
Prevalence of autoimmine thyroiditis In an Italian multiple sclerosis cohort 68
Retinal and choriocapillary vascular changes in early stages of multiple sclerosis: A prospective study 68
Disability outcomes in early-stage African American and White people with multiple sclerosis 67
Low serum 25‑hydroxy-vitamin D levels are associated with cognitive impairment in multiple sclerosis 63
Cerebellum and neurodegenerative diseases: Beyond conventional magnetic resonance imaging 60
The development of subcortical gray matter atrophy in multiple sclerosis: One size does not fit all 54
Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosis 54
Emergency medical care for multiple sclerosis: A five-year population study in the Campania Region (South Italy) 53
Identifying neuropsychological phenotypes in multiple sclerosis using latent profile analysis 51
Unraveling deep gray matter atrophy and iron and myelin changes in multiple sclerosis 50
An MRI evaluation of grey matter damage in African Americans with MS 47
Neuroimaging correlates of cognitive dysfunction in adults with multiple sclerosis 44
Prevalence and Incidence of Paramagnetic Rim Lesions in Multiple Sclerosis: A Systematic Review and Meta-Analysis 42
null 33
null 15
Totale 7.184
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.822
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.822
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202178 0 0 0 0 0 0 7 6 16 18 16 15
2021/2022267 14 5 10 9 6 21 9 11 26 17 54 85
2022/2023562 42 49 11 9 39 64 151 26 61 57 36 17
2023/2024432 15 61 42 37 26 77 15 44 18 9 52 36
2024/20252.370 104 97 17 47 78 167 236 163 136 214 877 234
2025/20263.192 475 458 559 563 894 175 68 0 0 0 0 0
Totale 7.184